business

Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update?

Yahoo Finance · Jun 30, 2026, 1:21 PM · Also reported by 3 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Why is Unicycive Therapeutics stock collapsing today? Investing.com Rapport Therapeutics stock hits all-time high at 42.36 USD Investing.com Moleculin reports positive interim data from AML trial

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Is Definium Therapeutics, Inc. (DFTX) Stock Poised for Further Gains After Positive Emerge Trial Update?

Also covered by

More in business